Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Public ClinicalTrials.gov record NCT00004635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blinded Randomized Crossover Phase III Study of Oral Thalidomide Versus Placebo in Patients With Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation
Study identification
- NCT ID
- NCT00004635
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- Thalidomide Drug
- goserelin Drug
- leuprolide acetate Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2000
- Primary completion
- Jan 29, 2005
- Completion
- Mar 29, 2010
- Last update posted
- May 21, 2018
2000 – 2010
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Holy Cross Hospital, Fort Lauderdale | Fort Lauderdale | Florida | 33308 | — |
| Louisiana State University | New Orleans | Louisiana | 70112-2282 | — |
| National Institutes of Health, Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
| Wayne State University Hutzel Hospital | Detroit | Michigan | 48201 | — |
| University of Minnesota | Minneapolis | Minnesota | 55415 | — |
| Columbia University | New York | New York | 10032-3784 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| Naval Medical Center, Portsmouth | Portsmouth | Virginia | 23708 | — |
| University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00004635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2018 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00004635 live on ClinicalTrials.gov.